CANCER
1PMPyU0
1PMPyU0
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Bloodwise 43<br />
HOW WE HOW WORK<br />
WE Our charity<br />
LEGAL STRUCTURE AND<br />
GOVERNANCE<br />
Bloodwise is a company limited by guarantee and<br />
incorporated in England on 17 October 1962. Our<br />
articles of association were last amended on 12 July<br />
2014.<br />
Formerly Leukaemia & Lymphoma Research,<br />
Bloodwise is a registered charity in England and<br />
Wales (charity number 216032) and in Scotland<br />
(charity number SC037529). The change of<br />
registration at Companies House was completed<br />
on 2 April 2015, Leukaemia & Lymphoma Research<br />
remains as an operating name with the Charity<br />
Commission and OSCR (the Scottish charity<br />
regulator) until September 2015.<br />
The Trustees are responsible for the governance<br />
and strategy of the charity. There are 11 Trustees<br />
who together bring a diversity of gender, skills and<br />
experience to enable the Board to operate effectively.<br />
Trustees are appointed for a renewable term of three<br />
years and are the directors of the company for the<br />
purposes of the Companies Act 2006.<br />
John Purser left the Board in July 2014 and Mike<br />
Williams will be retiring from the Board in July 2015,<br />
the Trustees are very grateful for their contribution<br />
and commitment to Bloodwise.<br />
The Trustees meet six times a year and delegate dayto-day<br />
responsibility for the running of the charity<br />
to the executive team. The Trustees also delegate<br />
specific responsibilities to various sub-committees.<br />
The operations of the organisation are covered by<br />
the Audit & Risk, Investment and Remuneration<br />
& Appointments committees. The Investment<br />
Committee benefits greatly from the expertise of<br />
Andrew Hutton, an independent advisor.<br />
During the year we concluded the business of<br />
the Patient Impact sub-Committee as it had been<br />
effective in bringing Trustee focus and responsibility<br />
to optimising patient impact, which now sits with the<br />
main board.<br />
The Board has increased input into our patient<br />
benefit strategy; more involvement in allocating<br />
resource to a broader range of solutions and greater<br />
scrutiny of performance and delivery.<br />
Susan Eastwood and her father<br />
RECRUITMENT,<br />
INDUCTION AND<br />
TRAINING OF TRUSTEES<br />
The Remuneration & Appointments Committee<br />
is responsible for recruiting Trustees, aiming to<br />
ensure a broad mix of skills and backgrounds. The<br />
committee meets regularly to review the selection of<br />
Trustees and succession planning for both the Board<br />
and the wider organisation.<br />
We’ve used a variety of recruitment methods to<br />
recruit Trustees, most recently through executive<br />
search and selection. On appointment new Trustees<br />
spend induction time with the Executive team and<br />
we aim to hold at least one of our Trustee meetings<br />
a year at a site where they can also experience our<br />
research or other patient activities.<br />
Trustees are also encouraged to attend our annual<br />
Impact Day to engage with fundraisers, researchers,<br />
clinicians, patients, volunteers and employees. We<br />
hold an annual development day, which this year<br />
was focused on shaping a strategic response to the<br />
findings of our patient need programme of research.<br />
Having recently conducted a thorough review,<br />
we continue to monitor the effectiveness of our<br />
governance. In the coming year we’ll reorganise our<br />
research committees to ensure that they continue to<br />
reflect the current research environment.<br />
Bloodwise trading as Leukaemia & Lymphoma Research Company limited by guarantee 738089<br />
Registered charity 216032 (England & Wales) SC037529 (Scotland)